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ABSTRACT 
This research was performed to characterize the hypoglycemic effect of ethanolic extract of Polypodium decumanum leaves in 
alloxanized diabetic rats. The ethanolic extract of Polypodium decumanum leaves was administered orally at different doses (250 
and 500 mg kg‐1) to normal rats. The dose of 500 mg kg‐1 was found to be more effective dose in oral route and it decreases Blood 
Glucose Level (BGL) by 22.2 % in normal healthy rats after 14 days of administration. After daily treatment with the both dose (250 
and 500 mg kg‐1) of ethanolic Polypodium decumanum extract for 21 days to severely Diabetic (FBG 300‐350 mg dL‐1) rats, the 
BGL reduced to 128.2 mg dL‐1  by 250 mg kg‐1  and 111 mg dL‐1  by 500 mg kg‐1. The findings of our study indicate the 
hypoglycemic and potential antihyperglycemic nature of the extract. It is not similar effective when compared with the standard drug 
Glibenclamide, but quite effective in reducing BGL.  It reduces blood glucose level up to 194.1, 119.4, 111 mg dL‐1  at successive 
days of 7, 14, 21, at the dose of 500 mg kg‐1  in rats compare with the standard drug which reduces blood glucose level up to 256.6, 
140.7, 101.2 mg dL‐1. We found that the ethanolic extract of plant Polypodium decumanumleaves is only 10 % less effective in 
reducing the BGL compare to standard drug (Glibenclamide). 
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INTRODUCTION 
Diabetes mellitus is a heterogeneous metabolic disorder 
as old as mankind and its incidence is considered to be 
high (4‐5%) all over the world1. Diabetes is a chronic 
disorder of carbohydrate, fat and protein metabolism 
characterized by elevation of both fasting and 
post‐paradinal blood sugar levels. The synthetic oral 
hypoglycemic agents can produce serious side effects
2,3
. 
In addition they are not considered safe for use during 
pregnancy
4
. Furthermore, after the recommendation 
made by
5
on diabetes mellitus investigation on 
hypoglycemic agents from medicinal plants have 
become important. Plants have played a major role in 
the introduction to new therapeutic agents. A multitude 
of herbs, spices and other plant materials have been 
described for the treatment of diabetes throughout the 
world
6 , 7 , 8 , 9
.  The medicinal plants might provide a 
useful source of new oral hypoglycemic compounds for 
development of pharmaceutical entities or as a dietary 
adjunct to existing therapies
10
.Few  of  the  plants  used  
for  the  treatment  of  diabetes  have received scientific 
or medical scrutiny and even the WHO expert 
committee on diabetes recommends that this area 
warrant further attention
5
. Despite the presence of 
known antidiabetic medicines in the pharmaceutical 
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market, screening for new antidiabetic sources from 
natural plants is still attractive because they contain 
substances that have an alternative and safe effect on 
diabetes mellitus. 
Polypodium Decumanum is terrestrial or epiphytic ferns 
with a creeping. The creeping   rhizomes are 8-15 mm in 
diameter with the golden brown scales. They are densely 
hairy or scaly rhizome bearing fronds at intervals along 
its length. The species differ in size, general appearance 
and in the character of the fronds, which are evergreen, 
persisting for 1-2 years, pinnate (rarely simple) and 
about 10-80 cm long and 10-50 cm broad. It is having up 
to 35 pinnae with multiple colors from bright green to 
glaucous green with having undulate margins. Several 
round sori or groups of spore-cases (sporangia) are 
borne on the back of the frond and run along each side 
of the pinna midrib and the minute spores are wind 
dispersed. it has the ability to regulate and support the 
growth of various cells in the body including the skin 
and brain. It is most commonly used in traditional 
medical system to treat skin disorders and upper 
respiratory infection; however newer research 
discovered an even more useful ability. That is to protect 
the brain cells from damage. 
Other uses of Polypodium Decumanum include 
treatment for vitiligo, kidney disease, cleansing the 
blood, an addition to detox formulation, improving and 
modulating the immune system, arthritis, and cancer. 
Polypodium Decumanum contains flavonoids, alkaloids 
and lipids. It is a rich source of lipids and fatty acids. 
The main plant chemicals identified in Samambaia 
includes adenosine, alkaloids, arachidonic acid, 
arabinopyranosides, calagualine, ecdysone, ecdysterone, 
eicosapentaenoic acid, elaidic acid, juglanin, 
kaempferols, linoleic acids, linolenic acids, melilotoside, 
oleic acid, ferulic acid, polypodaureine, ricinoleic acid, 
rutin, selligueain, and sulphoquinovosyl diacylglycerols. 
MATERIAL AND METHOD 
The Polypodium decumanum used in this study was 
procured from local market in indore and authenticated 
by Dr. D.K Srivastava, Scientist, College of Agriculture, 
ICAR division. 
Preparation of extract  
In the continuous hot extraction method the plant 
leaves extracted in Ethanol in 3 regular days at the 
temperature of 78‐80
0
C. The mixture was subsequently 
filtered and concentrated under reduced pressure at 
40
0
C. The extract yield was 26% w/w. 
Animal 
Albino mice 200‐250 g obtained from Institute of 
Pharmacy, Bundelkhand University, Jhansi, India were 
housed in animal house (App.  No.  716/02/a/CPCSEA)  
with  12/12  h  light/dark  cycle  at 21±20C  and  fed  
with  laborator  pellet chow and given water  ad libitum. 
Animals were acclimatized to their environment for one 
week prior to experimentation. Investigations using 
experimental animals were conducted in accordance 
with the internationally accepted principles for 
laboratory animal use and care as found in the United 
States Guidelines (United States National Institutes for 
Health Publication No. 85‐23, revised in 1985) and our 
ethical committee on animal care approved the protocol. 
Induction of Diabetes in Mice 
After 15 h fasting mice were injected in intraperitoneally 
with alloxan monohydrate (Sigma chemical, USA) 
dissolved in sterile normal saline at a dose of 120 kg
-1
 
body weight. To confirm diabetes, glycemia was daily 
determined after the administration of the last alloxan 
dose. Depending on their fasting blood glucose (FBG) 
level, the animals were divided arbitrarily in to two 
groups
9
, mild diabetic (MD) animals with FBG of 120-
250mg dl
-1
, severaly diabetic (SD) animals showing 
FBG 250-300mg dl
-1
. 
Estimation 
Blood glucose level was estimated by using one touch 
Glucometer (Accu-chek censor) of Roche Diagnostic, 
Germany for regular check-up. Blood sample were 
collected from tail veins. 
Biological Assays 
Oral glucose tolerance test (OGTT) 
Animals were fasted 18 hrs before the day of experiment 
with free access to water and were separated in 5 groups 
of 10 rats each. Animals of all groups were treated with 
an oral D-glucose load of 2 gm kg
-1
 by means of 
cannula, group third and fourth were treated orally with 
ethanolic extract at a dose of 250 mg kg
-1
 b.w. and 500 
mg kg
-1
 b.w each for 30 min before the oral 
administration of oral glucose load. Control animals 
were  treated with vehicle, blood sample were 
withdrawn from the cordal(tail) vein of each animals just 
after oral glucose administration 0 min, 30 min, 90 min 
and 120 min after glucose challenge and the fifth group 
received Glibenclamide (200 mg kg
-1
) as positive 
control. 
Statistical analysis 
All biological results expressed as mean + SEM. 
Significant differences among the groups were 
determined by one-way analysis of variance (ANOVA) 
followed by Dunnett-t test. Statistical significance was 
considered at P< 0.05. 
RESULT 
The plant extract of Polypodium decumanum leaves 
(ethanolic extract) showed antidiabetic activity by 
reducing blood glucose level significantly. It is also 
much effective when compare with the standard drug 
Glibenclamide. It reduce blood glucose level up to 
194.1, 119.4 and 111 mg dl
-1
 at successive days of 
7,14,21 at the dose of 500 mg kg
-1
 in rats compare with 
the standard drug which reduce blood glucose level up to 
256.6,140.7 and 101.2. We found that the ethanolic 
extract of plant Polypodium decumanum leaves is 9-10 
% less effective in reducing the blood glucose level 
compare to the standard drug (Glibenclamide). 
LD50 
The extract of the test substance (Polypodium 
decumanum) was found to be safe for further biological 
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studies as no toxic effect and lethality was observed up 
to 3000 mg kg
-1
 per oral in mice. Only the consumption 
of food was increased by 20 % in the dose of 2000 and 
3000 mg kg
-1.
during 4h, but remaining normal 
afterwards.
 
Table 1: Effect of Polypodium decumanum leaves (Ethanolic extract) on body weight 
   Treatment                                              Body weight in gm 
1 day 7 day  14 day 21 day 
Normal mice 169 + 4.5 170 + 4.9 173 + 5.5 178 + 5.4 
Control Diabetic Mice 171 + 7.5 156 + 8.5 145 + 7.5 139 + 7.3 
 Diabetic Mice + PD I 168 + 5.5
* 
161 + 5.5* 175 + 5.7* 180 + 5.6* 
Diabetic Mice + PD II 140 + 5.6* 133 + 7.5* 146 + 7.7* 159 + 7.8* 
Diabetic Mice + SD 
(Glibenclamide) 
135 + 7.4* 142 + 8.6* 150 + 7.6* 165 + 6.5* 
(Values are mean+ SEM, (n=5) *p< 0.05 when compare with control 
 
 
Figure 1: showing the effect of Polypodium decumanum plant extrat on body weight 
Fig. Bar showing body weight of treated (extract of Polypodium decumanum) and non treated, normal and diabetic mice with the 
standard drug (Glibenclamide) at day 1,7,14 and 21 day of growth.(NM= normal mice, DM= diabetic mice, PD=Polypodium 
decumanum plant extract) 
 
Table 2: Effect of Polypodium decumanum (Ethanolic extract) on Blood Glucose Level (mg/dl) 
   Treatment                                              Blood glucose level  
1 day 7 day 14 day 21 day 
Normal mice 96.5 + 1.77 95.0 + 2.56 95.8 + 1.97 94.7 + 2.01 
Control Diabetic Mice 335 .5+ 2.59 317.6 + 2.78 180.7 + 3.21 133.3 + 2.10 
Diabetic Mice + PD I(250mg/kgBW) 229 .8+ 3.45
* 
209 + 3.90* 162.4  + 3.76* 128.2  + 2.87* 
Diabetic Mice + PD II(500mg/kg BW 224 .2+ 2.53* 194.1 + 2.09* 139.4 + 3.21* 111 + 2.32* 
Diabetic Mice + SD (Glibenclamide) 309 + 7.4* 256.6 + 8.6* 140.7 + 7.6* 101.2 + 6.5* 
(values are mean + 7), (n=5) *p< 0.05 when compared with control 
 
 
 
(NM= normal mice, DM= diabetic mice, dose 1= 200mg/kg b.w plant extract, dose 2= 500 mg/ kg b.wplant extract) 
Figure 2: showing the effect of plant extract of Polypodium decumanum plant extract on blood glucose level 
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DISCUSSION 
The result showed important reduction of blood glucose 
level in healthy mice when administered the ethanolic 
extract of Polypodium decumanum extract by oral route. 
Ethanolic extract showed a dose-dependent effect on 
FBG up to a dose of 500 mg kg
-1
. After daily treatment 
with the dose (250 and 500 mg kg
-1
) of ethanolic 
Polypodium decumanum extract for 21 days to severely 
diabetic (FBG 300-350 mg dl
-1
) mice, the BGL reduced 
to 128.2 mg dl
-1
 and 111 mg dl
-1
 by 250 and 500 mg kg
-1
 
respectively. The findings of our study indicate the 
hypoglycemic and potential antihyperglycemic nature of 
the extract. It is not as much effective when compare to 
standard drug but its effect quite significant because it 
reduce the BGL 194.1 mg dl
-1
, 139 mg dl
-1
and 111 mg 
dl
-1
 with the dose of 500 mg kg
-1
 at successive days of 
7.14 and 21 of treatment with ethanolic extract of 
Polypodium decumanum. In the study on the effect of 
body weight the present study also showed that the body 
weight os the mice increased by 133, 146 and 159 gm at 
the successive days of 7.14 and 21 when given the 
treatment of ethanolic extract of Polypodium 
decumanum at the dose of 500 gm kg
-1
 compare to 
standard drug Glibenclamide which increase the body 
weight by 142, 150 and 165 gm at the successive days of 
7,14 and 21. So we found that the plant extract increases 
the body weight significantly when given the plant 
extract dose 500 mg kg
-1
 when compare to 250 mg kg
-1
. 
Recently it is reported that extract of Polypodium 
decumanum leaves exhibit significantly radical 
scavenging activity and thus antioxidant activity and the 
present finding indicates that administration of extract of 
Polypodium decumanum leaves confirms the possibility 
that the major function of the extract is on the protection 
of vital tissues including the pancreas, thereby reducing 
the causation of diabetes in these animals. So protective 
effect of extract of Polypodium decumanum on alloxan 
induced diabetes mice could be attributed directly to 
scavenging activity and for more extent to the 
regeneration properties of the extract.  
CONCLUSION 
In conclusion our study indicates that extract of 
Polypodium decumanum produced antihyperglycemic 
effect in experimental diabetes by providing a 
regenerative modification against damage caused by 
alloxan to endocrine cells of the pancreas. The use of 
this plant in diabetes id the supported but the active 
substances and cellular and molecular mechanism(s) of 
this pharmacological effect are still to be determined. 
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